FDA Clears Apple Watch to Detect Hypertension: The Cuff Era Ends

Millions of adults live with high blood pressure without ever knowing it, largely because traditional inflatable arm cuffs are awkward, noisy, and rarely used outside clinical checkups. That blind spot is about to change permanently. The U.S. Food and Drug Administration (FDA) has granted regulatory clearance for the Apple Watch to passively detect hypertension, marking an unprecedented milestone for consumer wearable technology.

Cuffless Tracking: How Apple's Optical Sensor Reads Arterial Pressure

Instead of physically constricting your arm with an inflatable bladder, Apple's hypertension detection engine relies on the built-in photoplethysmography (PPG) optical heart sensor. The system continuously tracks pulse wave velocity and microscopic changes in arterial wall distension as blood pumps through your wrist with every heartbeat.

Rather than delivering instant, pinpoint systolic and diastolic readings on command, the watch evaluates vascular patterns passively in the background across 30-day rolling observation periods. If the underlying algorithms spot persistent, recurring hallmarks of chronic stage 1 or stage 2 hypertension, watchOS delivers a direct proactive health alert recommending a clinical evaluation.

Rollout Scope, Clinical Nuances, and Real-World Trade-Offs

The cleared algorithm is slated to roll out across more than 150 countries and territories, launching on compatible models including Apple Watch Series 9, Series 10, Series 11, and the Ultra 2 and Ultra 3 lines. By embedding continuous passive surveillance directly onto wrists that wearers keep on all day, Apple estimates the system could alert over a million undiagnosed individuals within its first operational year alone.

Preserved Benefit: Continuous, silent arterial monitoring running 24/7 in the background without needing cumbersome inflatable cuffs, scheduled checks, or manual calibration. Explicit Trade-Off: Does not provide immediate numerical blood pressure figures (e.g. 120/80 mmHg), cannot detect acute sudden pressure spikes on demand, and requires continuous wear over a multi-week baseline before issuing its first notification.

To verify whether your specific wearable model packs the necessary optical sensor architecture, check our Apple Watch model identifier or inspect its complete biometric hardware profile in our sensor matrix.